CSS
GPCR icon

Cubist Systematic Strategies’s Structure Therapeutics GPCR Stock Holding History

Cubist Systematic Strategies’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$457K Sell
16,312
-55,378
-77% -$1.1M ﹤0.01% 2323
2025
Q2 		$1.49M Buy
71,690
+16,874
+31% +$371K 0.01% 1719
2025
Q1 		$949K Buy
+54,816
New +$1.34M 0.01% 1846
2024
Q2 		– Sell
-8,669
Closed -$356K – 3379
2024
Q1 		$372K Buy
+8,669
New +$366K ﹤0.01% 2776
2023
Q2 		– Sell
-805
Closed -$19.2K – 3823
2023
Q1 		$19.2K Buy
+805
New +$18.9K ﹤0.01% 3674

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cubist Systematic Strategies's GPCR Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Structure Therapeutics (GPCR) stake by 77% in Q3 2025, selling an estimated $1.1M and leaving 16,312 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Cubist Systematic Strategies first reported a position in GPCR in Q1 2023 and has held it in 5 quarters since. The position peaked at $1.49M in Q2 2025. 156 funds tracked by Wall St. Rank hold GPCR as of Q3 2025.

  • Cubist Systematic Strategies held 16,312 shares of Structure Therapeutics worth $457K as of Q3 2025.
  • Cubist Systematic Strategies sold 55,378 Structure Therapeutics shares in Q3 2025, an estimated $1.1M.
  • Structure Therapeutics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2323 holding.
  • Cubist Systematic Strategies first reported a position in Structure Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Cubist Systematic Strategies's Structure Therapeutics position peaked at $1.49M in Q2 2025.
  • 156 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.